ATE385811T1 - Identifizierung zielgerichteter faltungsstellen in peptiden und proteinen - Google Patents
Identifizierung zielgerichteter faltungsstellen in peptiden und proteinenInfo
- Publication number
- ATE385811T1 ATE385811T1 AT01994412T AT01994412T ATE385811T1 AT E385811 T1 ATE385811 T1 AT E385811T1 AT 01994412 T AT01994412 T AT 01994412T AT 01994412 T AT01994412 T AT 01994412T AT E385811 T1 ATE385811 T1 AT E385811T1
- Authority
- AT
- Austria
- Prior art keywords
- interest
- target
- binding
- peptides
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25684200P | 2000-12-19 | 2000-12-19 | |
US30483501P | 2001-07-11 | 2001-07-11 | |
US32783501P | 2001-10-04 | 2001-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE385811T1 true ATE385811T1 (de) | 2008-03-15 |
Family
ID=27400993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01994412T ATE385811T1 (de) | 2000-12-19 | 2001-12-19 | Identifizierung zielgerichteter faltungsstellen in peptiden und proteinen |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1379283B1 (de) |
JP (1) | JP2005501220A (de) |
AT (1) | ATE385811T1 (de) |
CA (1) | CA2436789A1 (de) |
DE (1) | DE60132820D1 (de) |
WO (1) | WO2002064734A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7351690B2 (en) | 2000-12-19 | 2008-04-01 | Palatin Technologies, Inc. | Knockout identification of target-specific sites in peptides |
FR2835528B1 (fr) * | 2002-02-01 | 2004-03-12 | Inst Europ Biolog Cellulaire | Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique |
AR038568A1 (es) | 2002-02-20 | 2005-01-19 | Hoffmann La Roche | Anticuerpos anti-a beta y su uso |
ATE358136T1 (de) * | 2002-10-23 | 2007-04-15 | Ct For Res And Technology Hell | Prionen-bindende peptidsequenzen |
JP2007510643A (ja) * | 2003-11-06 | 2007-04-26 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 医薬化合物 |
EP1861127A1 (de) | 2005-03-10 | 2007-12-05 | Bayer Schering Pharma Aktiengesellschaft | Chelatoren für radioaktiv markierte konjugate mit stabilisierender seitenkette |
EP1700608A1 (de) * | 2005-03-10 | 2006-09-13 | Schering AG | Chelate für radioaktiv markierte Konjugate mit einer stabilisierenden Seitenkette |
UY30003A1 (es) | 2005-12-12 | 2007-08-31 | Hoffmann La Roche | Anticuerpos glicosilados en la region variable |
FR2971784B1 (fr) * | 2011-02-18 | 2015-01-02 | Isp Investments Inc | Nouveaux peptides activateurs de la synthese des proteines de la matrice extracellulaire et compositions cosmetiques les comprenant |
WO2016207240A1 (en) | 2015-06-24 | 2016-12-29 | F. Hoffmann-La Roche Ag | Anti-transferrin receptor antibodies with tailored affinity |
AR106189A1 (es) | 2015-10-02 | 2017-12-20 | Hoffmann La Roche | ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO |
JP6657392B2 (ja) | 2015-10-02 | 2020-03-04 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 二重特異性抗ヒトcd20/ヒトトランスフェリン受容体抗体及び使用方法 |
US10759837B2 (en) | 2015-11-09 | 2020-09-01 | The University Of British Columbia | Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide |
CN108350052A (zh) | 2015-11-09 | 2018-07-31 | 英属哥伦比亚大学 | 淀粉样蛋白β中间区域中的表位及其构象选择性抗体 |
US20180125920A1 (en) | 2016-11-09 | 2018-05-10 | The University Of British Columbia | Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions |
CN107337709B (zh) * | 2017-06-29 | 2021-03-02 | 安徽省农业科学院农产品加工研究所 | 一种高锌螯合活性锌螯合肽及其应用 |
WO2020242765A1 (en) | 2019-05-31 | 2020-12-03 | Rubryc Therapeutics, Inc. | Meso-scale engineered peptides and methods of selecting |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200504A (en) * | 1990-10-02 | 1993-04-06 | The Scripps Research Institute | Metallopeptides having stabilized secondary structures |
US6027711A (en) * | 1995-06-07 | 2000-02-22 | Rhomed Incorporated | Structurally determined metallo-constructs and applications |
US5891418A (en) * | 1995-06-07 | 1999-04-06 | Rhomed Incorporated | Peptide-metal ion pharmaceutical constructs and applications |
US6331285B1 (en) * | 1996-06-05 | 2001-12-18 | Palatin Technologies, Inc. | Structurally determined cyclic metallo-constructs and applications |
US6083758A (en) * | 1997-04-09 | 2000-07-04 | California Institute Of Technology | Method for screening peptides for metal coordinating properties and fluorescent chemosensors derived therefrom |
JP2002536295A (ja) * | 1998-12-14 | 2002-10-29 | パラチン テクノロジーズ, インク. | 金属ペプチド組合せライブラリ及びその利用法 |
WO2001013112A1 (en) * | 1999-08-12 | 2001-02-22 | Palatin Technologies, Inc. | Melanocortin metallopeptide constructs, combinatorial libraries and applications |
-
2001
- 2001-12-19 JP JP2002565049A patent/JP2005501220A/ja active Pending
- 2001-12-19 CA CA002436789A patent/CA2436789A1/en not_active Abandoned
- 2001-12-19 DE DE60132820T patent/DE60132820D1/de not_active Expired - Lifetime
- 2001-12-19 EP EP01994412A patent/EP1379283B1/de not_active Expired - Lifetime
- 2001-12-19 WO PCT/US2001/050075 patent/WO2002064734A2/en active IP Right Grant
- 2001-12-19 AT AT01994412T patent/ATE385811T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2005501220A (ja) | 2005-01-13 |
EP1379283A4 (de) | 2005-01-19 |
EP1379283B1 (de) | 2008-02-13 |
DE60132820D1 (de) | 2008-03-27 |
EP1379283A2 (de) | 2004-01-14 |
CA2436789A1 (en) | 2002-08-22 |
WO2002064734A2 (en) | 2002-08-22 |
WO2002064734A3 (en) | 2003-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE385811T1 (de) | Identifizierung zielgerichteter faltungsstellen in peptiden und proteinen | |
Arora et al. | Chemical crosslinking: Role in protein and peptide science | |
Rappsilber | The beginning of a beautiful friendship: cross-linking/mass spectrometry and modelling of proteins and multi-protein complexes | |
Cheadle et al. | Identification of a Src SH3 domain binding motif by screening a random phage display library. | |
Eaton | Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures | |
ATE480562T1 (de) | Veränderung von fcrn-bindungsaffinitäten oder von serumhalbwertszeiten von antikörpern mittels mutagenese | |
CY1108998T1 (el) | Πρωτεϊνες που δεσμευονται με οστεοπροτεγερινη και υποδοχεις | |
WO2003102157A3 (en) | Synthetic antibody phage libraries | |
CY1116863T1 (el) | Πρωτεϊνη δεσμευσης υποδοχεα nogo | |
ATE344456T1 (de) | Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen | |
HUP0200400A2 (hu) | Fehérjék izolálása és elemzése | |
US20090227468A1 (en) | Methods For Immuno-Detection Of Epitopes On Molecules And For Detection Of Interactions Of Molecules Via Fluorescent Dyes | |
US20160054331A1 (en) | Method for the detection and/or enrichment of analyte proteins and/or analyte peptides from a complex protein mixture | |
Trier et al. | Physical characteristics of a citrullinated pro-filaggrin epitope recognized by anti-citrullinated protein antibodies in rheumatoid arthritis sera | |
WO2004090154A3 (en) | Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis | |
DE60129239D1 (de) | Kit und verfahren zur bestimmung von protein esm-1 | |
US20020028450A1 (en) | Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes | |
BRPI0520902A2 (pt) | Anticorpo monoclonal ou fragmento de ligação a antigeno do mesmo que se liga a proteinas psca para disgnostico de cancer, metodo para produção dos mesmos, hib'ridoma, polinucleotideo, vetor, celula, composição, ensaio para detectar a presença de uma proteina'psca e metodo de detecção de uma proteina psca | |
WO2004092741A3 (en) | Mapping discontinuous antibody or aptamer epitopes for protein structure determination and other applications | |
DK1644513T3 (da) | Assay til detektion af proteinbinding | |
ATE306666T1 (de) | Verfahren zur eiweissanalyse | |
ES2115750T3 (es) | Ensayo de captura de proteinas de union. | |
Brown et al. | Development of a new protein labeling system to map subunits and domains of macromolecular complexes for electron microscopy | |
WO2004075830A3 (en) | Knockout identification of target-specific sites in peptides | |
WO2007095378A3 (en) | Mass tagging for quantitative analysis of biomolecules using 13c labeled phenylisocyanate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |